Valuation: DaShenLin Pharmaceutical Group Co., Ltd.

Market Cap 21.36B 3.15B 2.76B 2.57B 2.36B 4.44B 304B 4.51B 30.57B 11.97B 149B 11.84B 11.59B 515B P/E 2026 *
14.4x
P/E 2027 * 12.5x
Enterprise Value 17.85B 2.64B 2.31B 2.14B 1.97B 3.71B 254B 3.77B 25.54B 9.99B 124B 9.89B 9.68B 430B EV / Sales 2026 *
0.6x
EV / Sales 2027 * 0.53x
Free-Float
34.77%
Yield 2026 *
4.8%
Yield 2027 * 5.29%
1 day-0.79%
1 week-4.67%
Current month+24.82%
1 month+16.16%
3 months+5.57%
6 months-4.19%
Current year+6.47%
1 week 18.37
Extreme 18.37
19.49
1 month 14.39
Extreme 14.39
19.96
Current year 14.39
Extreme 14.39
21.78
1 year 14.39
Extreme 14.39
21.78
3 years 11.92
Extreme 11.92
30.22
5 years 11.92
Extreme 11.92
39.47
10 years 11
Extreme 11.0028
61.63
Manager TitleAgeSince
Chief Executive Officer 44 2019-02-27
Director of Finance/CFO 44 2018-05-09
Human Resources Officer 48 -
Director TitleAgeSince
Director/Board Member 63 2016-08-07
Chairman 59 2013-07-15
Chairman 48 2015-05-27
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%-4.67%+11.34%-30.34% 3.18B
-0.85%-0.99%-22.99%-9.30% 6.01B
+0.46%+1.92%-8.72%-29.52% 3.88B
-3.54%-2.57%-39.82%-15.28% 3.24B
+0.11%-0.05%-30.31%-48.82% 3.16B
-0.25%+3.12%-18.69%+0.66% 2.56B
-2.79%-0.50%+95.62% - 2.59B
-3.17%-4.18%-1.27%+33.08% 1.67B
-1.02%+0.22%-35.02%-34.46% 1.58B
-1.58%-0.53%+46.97%+104.71% 1.15B
Average -1.34%-0.39%-0.29%-3.25% 2.9B
Weighted average by Cap. -1.15%-0.13%-5.66%-13.17%

Financials

2026 *2027 *
Net sales 29.91B 4.42B 3.87B 3.59B 3.3B 6.22B 426B 6.31B 42.79B 16.75B 209B 16.58B 16.22B 720B 33.03B 4.88B 4.27B 3.97B 3.65B 6.87B 471B 6.97B 47.27B 18.5B 230B 18.31B 17.92B 796B
Net income 1.48B 219M 192M 178M 164M 309M 21.15B 313M 2.12B 831M 10.35B 823M 805M 35.76B 1.71B 253M 222M 206M 189M 357M 24.43B 362M 2.45B 960M 11.95B 950M 930M 41.3B
Net Debt -3.52B -520M -455M -423M -388M -732M -50.15B -743M -5.04B -1.97B -24.54B -1.95B -1.91B -84.76B -4.01B -592M -519M -482M -443M -834M -57.14B -846M -5.74B -2.25B -27.96B -2.22B -2.17B -96.58B
Logo DaShenLin Pharmaceutical Group Co., Ltd.
DaShenLin Pharmaceutical Group Co Ltd is a China-based company principally engaged in the pharmaceutical retailing business. The Company is mainly engaged in the chain retail business of Chinese and Western patent medicines, ginseng and antler tonic medicinal materials and Chinese herbal medicine slices, health products, medical devices and other commodities. The Company is also involved in the production of Chinese herbal medicine slices, ginseng and antler tonic, health products, Chinese and Western patent medicines. The Company's brands include Dong Zi Yun Xuan, Cocoking, Nobe Huale, Dongteng Ejiao, and Fuer. The Company mainly conducts business within domestic market.
Employees
41,141
Date Price Change Volume
26-07-22 CN¥18.76 -0.79% 10,232,664
26-07-21 CN¥18.91 +0.48% 10,096,000
26-07-20 CN¥18.82 +1.35% 10,137,860
26-07-17 CN¥18.57 -3.53% 9,652,935
26-07-16 CN¥19.25 0.00% 10,880,532
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
18.76CNY
Average target price
24.70CNY
Spread / Average Target
+31.66%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 603233 Stock